These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 35718400)

  • 21. Ziconotide: new drug. Limited analgesic efficacy, too many adverse effects.
    Prescrire Int; 2008 Oct; 17(97):179-82. PubMed ID: 19530373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intrathecal combination of ziconotide and morphine for refractory cancer pain: a rapidly acting and effective choice.
    Alicino I; Giglio M; Manca F; Bruno F; Puntillo F
    Pain; 2012 Jan; 153(1):245-249. PubMed ID: 22082570
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aseptic arachnoiditis in a patient treated with intrathecal morphine infusion: symptom resolution on switch to ziconotide.
    Codipietro L; Maino P
    Neuromodulation; 2015 Apr; 18(3):217-20; discussion 220. PubMed ID: 24945709
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ziconotide, a new N-type calcium channel blocker, administered intrathecally for acute postoperative pain.
    Atanassoff PG; Hartmannsgruber MW; Thrasher J; Wermeling D; Longton W; Gaeta R; Singh T; Mayo M; McGuire D; Luther RR
    Reg Anesth Pain Med; 2000; 25(3):274-8. PubMed ID: 10834782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ziconotide, an intrathecally administered N-type calcium channel antagonist for the treatment of chronic pain.
    Wermeling DP
    Pharmacotherapy; 2005 Aug; 25(8):1084-94. PubMed ID: 16207099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Short-Term Outcomes of a High-Volume, Low-Concentration Bolus Starting Dose Technique With Ziconotide: A Case Series.
    Lindley D
    Neuromodulation; 2021 Oct; 24(7):1209-1214. PubMed ID: 34252245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intrathecal Drug Delivery.
    De Andrés J; Rubio-Haro R; De Andres-Serrano C; Asensio-Samper JM; Fabregat-Cid G
    Methods Mol Biol; 2020; 2059():75-108. PubMed ID: 31435916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of Low Dose Ziconotide as First-Line Intrathecal Monotherapy.
    Prusik J; Argoff C; Peng S; Pilitsis JG
    Neuromodulation; 2017 Jun; 20(4):386-391. PubMed ID: 27492135
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Continuous intrathecal morphine treatment for chronic pain of nonmalignant etiology: long-term benefits and efficacy.
    Kumar K; Kelly M; Pirlot T
    Surg Neurol; 2001 Feb; 55(2):79-86; discussion 86-8. PubMed ID: 11301086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intrathecal drug administration in chronic pain syndromes.
    Ver Donck A; Vranken JH; Puylaert M; Hayek S; Mekhail N; Van Zundert J
    Pain Pract; 2014 Jun; 14(5):461-76. PubMed ID: 24118774
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Management of pain from osteoporotic vertebral fractures with continuous intrathecal administration of morphine].
    Piva B; Shaladi A; Crestani F; Saltari R; Micheletto G; Pinato G
    Recenti Prog Med; 2007 Apr; 98(4):225-31. PubMed ID: 17547359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Chronic intrathecal drug administration for the control of intractable pain].
    Taira T
    Brain Nerve; 2008 May; 60(5):509-17. PubMed ID: 18516973
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Continuous intrathecal morphine infusion in patients with vertebral fractures due to osteoporosis.
    Shaladi A; Saltari MR; Piva B; Crestani F; Tartari S; Pinato P; Micheletto G; Dall'Ara R
    Clin J Pain; 2007; 23(6):511-7. PubMed ID: 17575491
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intrathecal Morphine Infusion Therapy in Management of Chronic Pain: Present and Future Implementation in Korea.
    Kim EJ; Moon JY; Kim YC; Park KS; Yoo YJ
    Yonsei Med J; 2016 Mar; 57(2):475-81. PubMed ID: 26847303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Relationship Between the Mechanisms of Action and Safety Profiles of Intrathecal Morphine and Ziconotide: A Review of the Literature.
    Webster LR
    Pain Med; 2015 Jul; 16(7):1265-77. PubMed ID: 25645109
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment challenges and complications with ziconotide monotherapy in established pump patients.
    Thompson JC; Dunbar E; Laye RR
    Pain Physician; 2006 Apr; 9(2):147-52. PubMed ID: 16703976
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spinal cord compression by catheter granulomas in high-dose intrathecal morphine therapy: case report.
    Cabbell KL; Taren JA; Sagher O
    Neurosurgery; 1998 May; 42(5):1176-80; discussion 1180-1. PubMed ID: 9588567
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS: a randomized controlled trial.
    Staats PS; Yearwood T; Charapata SG; Presley RW; Wallace MS; Byas-Smith M; Fisher R; Bryce DA; Mangieri EA; Luther RR; Mayo M; McGuire D; Ellis D
    JAMA; 2004 Jan; 291(1):63-70. PubMed ID: 14709577
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ziconotide: A rapid detoxification protocol for the conversion from intrathecal morphine--the Raffaeli Detoxification Model.
    Raffaeli W; Righetti D; Sarti D; Balestri M; Ferioli I; Monterubbianesi MC; Caminiti A
    J Opioid Manag; 2011; 7(1):21-6. PubMed ID: 21434581
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ziconotide--a novel neuron-specific calcium channel blocker for the intrathecal treatment of severe chronic pain--a short review.
    Klotz U
    Int J Clin Pharmacol Ther; 2006 Oct; 44(10):478-83. PubMed ID: 17063978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.